Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

KRTAP9-L1 Inhibitors

KRTAP9-L1 inhibitors represent a class of chemical compounds that target the specific function or interaction of the keratin-associated protein 9 locus 1 (KRTAP9-L1) gene product. The KRTAP9 family, in general, is involved in the structural composition and regulation of keratin, which forms an essential part of the cytoskeletal architecture in epithelial cells. By influencing the physical properties of keratin filaments, KRTAP9 proteins play a crucial role in maintaining the mechanical strength and flexibility of structures like hair, nails, and the outer layers of the skin. The inhibitors of KRTAP9-L1 are designed to interfere with these proteins' ability to properly interact with keratin, potentially altering the organization, assembly, or disassembly of keratin filaments. These interactions are highly specific, as the proteins of the KRTAP family are closely related, and inhibitors need to be designed to selectively bind or deactivate particular isoforms like KRTAP9-L1 without affecting others.

On a molecular level, KRTAP9-L1 inhibitors might function through a range of mechanisms. They could block binding sites necessary for protein-protein interactions, or they might alter the protein's conformation, preventing it from adopting the structural requirements needed for its biological function. These inhibitors may affect the electrostatic interactions or hydrophobic domains of KRTAP9-L1, which are essential for its stability and association with keratin filaments. The structural basis of KRTAP9-L1 and its inhibitors could involve a variety of chemical scaffolds, including small organic molecules or peptides, which interact with the protein's active or allosteric sites. This specificity is key, as any interference in KRTAP9-L1 functionality could lead to changes in the organization of keratin structures and thus significantly alter their mechanical properties. Understanding the detailed binding dynamics and structural modifications that KRTAP9-L1 inhibitors induce is crucial for elucidating their broader impact on keratin filament architecture.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Inhibits protein synthesis, which can decrease overall protein levels, including KRTAP9-L1.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

A proteasome inhibitor that can increase protein levels by preventing degradation, potentially affecting KRTAP9-L1 stability.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Inhibits RNA polymerase, which can suppress RNA synthesis and potentially reduce KRTAP9-L1 expression.

Puromycin dihydrochloride

58-58-2sc-108071
sc-108071B
sc-108071C
sc-108071A
25 mg
250 mg
1 g
50 mg
$42.00
$214.00
$832.00
$66.00
394
(16)

Causes premature chain termination during protein translation, possibly reducing KRTAP9-L1 synthesis.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Inhibits lysosomal degradation pathways, which could affect the turnover of cellular proteins, including KRTAP9-L1.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

An mTOR inhibitor that can decrease protein synthesis and also modulate autophagy, potentially impacting KRTAP9-L1 levels.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

A proteasome inhibitor that can increase the levels of proteins, potentially influencing the stability of KRTAP9-L1.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

A potent inhibitor of RNA polymerase II, which can lead to decreased mRNA synthesis for many genes, possibly including KRTAP9-L1.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

An inhibitor of histone deacetylases (HDACs), which can change chromatin structure and affect gene expression, potentially impacting KRTAP9-L1 expression.

Geldanamycin

30562-34-6sc-200617B
sc-200617C
sc-200617
sc-200617A
100 µg
500 µg
1 mg
5 mg
$39.00
$59.00
$104.00
$206.00
8
(1)

Binds to Hsp90 and inhibits its function, which can affect the stability and function of client proteins, potentially including KRTAP9-L1.